This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 May 6;137(18):2424-2425.

doi: 10.1182/blood.2020010323.

HIF-2 inhibitor, erythrocytosis, and pulmonary hypertension

Josef T Prchal^{1

2}, Victor R Gordeuk³

Affiliations

PMID: 33956067
DOI: 10.1182/blood.2020010323

Free article

Editorial

HIF-2 inhibitor, erythrocytosis, and pulmonary hypertension

Josef T Prchal et al. Blood. 2021.

Free article

. 2021 May 6;137(18):2424-2425.

doi: 10.1182/blood.2020010323.

Authors

Josef T Prchal^{1

2}, Victor R Gordeuk³

Affiliations

¹ University of Utah.
² Huntsman Cancer Center at Salt Lake City.
³ University of Illinois at Chicago.

PMID: 33956067
DOI: 10.1182/blood.2020010323

No abstract available

PubMed Disclaimer

Comment on

Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.
Ghosh MC, Zhang DL, Ollivierre WH, Noguchi A, Springer DA, Linehan WM, Rouault TA. Ghosh MC, et al. Blood. 2021 May 6;137(18):2509-2519. doi: 10.1182/blood.2020009138. Blood. 2021. PMID: 33512384 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information